Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011502

CHIEF FINANCIAL OFFICER gave up 479 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 990 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-26 Option exercise +990 27,488 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-26 Shares withheld for taxes −479 $21.37 $10,234 27,009 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-04-26 Option exercise · Restricted Share Unit −990 0 D
Loading xslF345X05/form4-04292025_080403.xml…